Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients

Summary

The purpose of this study is evaluate the safety and tolerability of Diannexin in kidney transplant recipients.

Timeline

Start

2008-02

Primary completion

2009-01

Completion

2010-02

Publications

• Cheng EY, Sharma VK, Chang C, Ding R, Allison AC, Leeser DB, Suthanthiran M, Yang H. Diannexin decreases inflammatory cell infiltration into the islet graft, reduces beta-cell apoptosis, and improves early graft function. Transplantation. 2010 Oct 15;90(7):709-16. doi: 10.1097/TP.0b013e3181ed55d8.

Drugs

Indications

No indication recorded.